Gengigel Prof
Gengigel Prof, licence 80060902: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Ricerfarma S.R.L.
- NPN or DIN-HM
- 80060902
- Status
- Active licence
- Licence date
- 14 May 2015
- Revision date
- 11 January 2016
- Form
- Liquide dentaire, suspension
- Route of administration
- Dentaire
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide hyaluronique Source : Hyaluronate de sodium | 1.0 milligramme | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 1.0 milligramme | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 0.8 % | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 0.8 % | Not calculated |
Non-medicinal ingredients
Poly(alcool vinylique), Eau distillée, Hydroxide de sodium, Alcool, Gomme de cellulose, PEG-40 Hydrogenated Castor Oil, Benzyl alcohol, p-hydroxy-, Polycarbophil, xylitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Droppers | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Anti-inflammatory effect. Effective against gingival pockets in conjunction with periodontal therapy. In conjunction with non-surgical periodontal therapy (scaling and root planing), reduces bleeding in patients with chronic periodontitis. Promotes and accelerates gingival re-attachment after surgical trauma. Success adjunct treatment to scaling and root planing in the treatment of chronic periodontal disease.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80060902
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.